KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,388 | -31.3% | 19,884 | +13.7% | 0.00% | – |
| Q2 2023 | $402,187 | -46.1% | 17,494 | -30.6% | 0.00% | – |
| Q1 2023 | $746,705 | +42.6% | 25,201 | +20.1% | 0.00% | – |
| Q4 2022 | $523,686 | +50.5% | 20,981 | +31.3% | 0.00% | – |
| Q3 2022 | $348,000 | -12.3% | 15,976 | -20.8% | 0.00% | – |
| Q2 2022 | $397,000 | -71.9% | 20,176 | -39.5% | 0.00% | -100.0% |
| Q1 2022 | $1,412,000 | -37.3% | 33,366 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $2,251,000 | +7.6% | 35,450 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $2,092,000 | +125.9% | 35,619 | +86.5% | 0.00% | – |
| Q2 2021 | $926,000 | +250.8% | 19,100 | +181.0% | 0.00% | – |
| Q1 2021 | $264,000 | -42.6% | 6,798 | -8.3% | 0.00% | – |
| Q4 2020 | $460,000 | – | 7,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |